Last edition
News about "MSN Laboratories "
Torrent Pharma Recalls Select Semalix Injection Batches Following API-Related Quality Issue
Torrent Pharmaceuticals has initiated a recall of select batches of Semalix Injection 2 mg and 4 mg after certain semaglutide batches failed quality specifications due to an API-related issue.
MSN Laboratories | 10/07/2026 | By News Bureau
Dr. Reddy's Announces the First-to-Market Launch of Bosutinib Tablets 400 mg
Dr. Reddy’s has launched Bosutinib Tablets 400 mg in the US, becoming the first generic equivalent of Bosulif available in the market.
MSN Laboratories | 15/06/2026 | By News Bureau
MSN Laboratories Launches SEMABEST, India's First Semaglutide After Patent Expiry
MSN Laboratories launches SEMABEST, India’s first semaglutide post patent expiry, priced 50 percent lower than the innovator drug and available as a pre-filled pen for improved patient access.
MSN Laboratories | 15/04/2026 | By News Bureau | 187
MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for Indian Patients
The launch of JAK inhibitors enhances the accessibility and affordability of advanced treatments for patients suffering from various autoimmune diseases, including Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis, Crohn's Disease and Atopic Dermatitis. Both molecules are also approved by the US FDA.
MSN Laboratories | 14/10/2025 | By Dineshwori | 825
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy